Rating History for Trevi Therapeutics (TRVI) by Leerink Partners

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/2/2026 Roanna Ruiz Maintain Outperform
(N/A)
21.00
(16.00)
 
 
  Details